Events & Conferences

10-15 Nov 21 – LSX Inv€$tival Showcase conference.

Small Pharma is participating in the LSX Inv€$tival ShowcaseTM conference.

Peter Rands, Chief Executive Officer, and Dr. Carol Routledge, Chief Medical and Scientific Officer, are presenting a webcast on the Company’s progress in the development of N,N-dimethyltryptamine (“DMT”) assisted therapy for the treatment of Major Depressive Disorder (“MDD”), which is available on-demand via the conference platform.

Small Pharma’s management team is also available for one-on-one in-person meetings on November 15 in London, England. To schedule a meeting, please contact LifeSci Advisors at

About Small Pharma

We’re a mental health drug development company that’s accelerating the development of fast acting antidepressant treatments using DMT based therapies. We’re dedicated to making a difference.

Get Small Pharma
Investor Updates

    Investor Deck

    Follow us: